Fate Therapeutics
Fate Therapeutics initiates phase 1 trial for solid tumour treatment
January 9, 2024Research and Development Fate Therapeutics, Oncology, solid tumours
Fate Therapeutics has announced that it has begun enrollment for the phase 1 clinical trial of FT825/ONO-8250, a multiplexed-engineered, chimeric …
